Results 131 to 140 of about 1,039,949 (281)

An Open-Source Systematic Reviews Integrated System (OSSYRIS) - Streamlining Processes and Standardising Data Structures. [PDF]

Cochrane Evid Synth Methods
Bosch-Capblanch X, Auer C, Sayem ASM, Deschamps G, Camacho S, Segura L, Al-Aidroos S, Sabblah GT, Wyss K.   +8 more
europepmc   +1 more source

On Reviewing the Reviewers

Annals of Emergency Medicine, 1999
openaire   +2 more sources

ABL kinase‐dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains

FEBS Letters, EarlyView.
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens, Brendan W. Chandler, Anna M. Schmoker, Jaye L. Weinert, Charlotte A. Kearns, Warren T. Yacawych, Amila Šemić, Alicia M. Ebert, Bryan A. Ballif   +8 more
wiley   +1 more source

. Evaluadores

Vitae, 2014
. Reviewers
doaj  

Peer review: historical evolution and reviewers' learning. [PDF]

Insights Imaging
Aparisi Gómez MP, Sardanelli F.
europepmc   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

Molecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti   +11 more
wiley   +1 more source

Author's response to reviewers' commentary on Constructing risk: Psychology, medicine and child welfare

, 1997
This response to the commentaries, by the Reviewers, has been included as the Reviewers’ comments have sparked a response from the Authors which adds further to this debate about the controversial issues surrounding ...
Kendall, Gavin P.
core  

Tips and tricks for addressing and responding to peer reviews. [PDF]

Conserv Physiol
Tomlinson S, Clements JC, Cooke SJ, Fuller A, O'Boyle B.   +4 more
europepmc   +1 more source

Review: Book Review [PDF]

The Computer Journal, 1969
openaire   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source